Advarra, the premier provider of IRB, IBC and research quality and compliance consulting services in North America, has completed all integration activities. This includes harmonization of SOPs and the transfer of legacy study information into the Advarra Center for IRB Intelligence (CIRBI) Platform and the Advarra IBC Platform.
Clients continued to experience a seamless suite of solutions while Advarra completed the integration, which was necessary following the merger of two leading IRB services companies into Advarra. An internal audit confirmed the study data transfer project was accomplished with zero service interruptions for customers and full data integrity. All customer agreements have been updated to Advarra.
“Advarra now operates under a single electronic system with unified processes and procedures, which allows us to continue to focus on delivering efficient and responsive research compliance services to our clients,” said Pat Donnelly, CEO of Advarra. “Fully integrated processes also will enable us to further develop our service offerings in a thoughtful and meaningful way.”
Throughout the integration process, Advarra has remained committed to being transparent and responsive, working closely with clients, staff members, regulatory agencies and business partners to standardize services and processes to deliver the high-quality research compliance capabilities the research community expects from the organization.
“We’re grateful to our client partners who helped us prepare and plan the migration tasks, allowing our expert team to finish integration ahead of schedule in just 10 months,” said Jeff Wendel, President and COO of Advarra. “We look forward to continuing our legacy as the premier provider of IRB, IBC and research quality and compliance consulting services in North America.”
Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research review are met, while putting participants first and meeting complex human research protection oversight requirements. Advarra supports all phases of research across multiple therapeutic areas. For more information, visit advarra.com.